Hidradenitis Suppurativa: Managing a Complex Disease with Multiple Comorbidities

Abstract

Hidradenitis suppurativa (HS), a chronic skin disorder of the intertriginous areas that frequently presents with draining abscesses, deep painful nodules, possible sinus tracts, and the development of widespread scarring, can significantly impact a patient’s quality of life (QoL), therefore early diagnosis and initiation of treatment is vital. This article reviews the existing evidence-based treatment guidelines for HS as described in the literature, stages of HS as categorized by the Hurley system, available treatment options, and short- and long-term disease management strategies, all key to improved patient satisfaction. Common physical and psychological comorbidities of HS, such as hypertension, metabolic syndrome, polycystic ovarian syndrome, depression, and anxiety are also discussed with emphasis on the dermatology physician assistant’s role in comorbidities screening and managing referrals when necessary. This program has been CME reviewed and is approved for a maximum of 1 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. Approval is valid for 1 year from the issue date of June 1, 2022. Participants may submit the self-assessment exam at any time during that period. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. SDPA members may access the post-test at https://www.dermpa.org/JDPA_Exams (https://www.dermpa.org/JDPA_Exams)